Barry Friend

Title: Barry Friend: Innovator in Film Coating Technology

Introduction

Barry Friend, an inventor based in Dartford, GB, has made notable contributions to the field of pharmaceuticals through his innovative work in film coatings. With a keen focus on enhancing oral dosage forms, Friend's inventions demonstrate the intersection of chemistry and practical application in medicine.

Latest Patents

Barry Friend holds a significant patent titled "Film coatings containing fine particle size detackifiers and substrates coated therewith." This invention is aimed at developing film coating compositions specifically designed for oral dosage forms, including compressed tablets and other orally-ingestible substrates. The key aspect of this invention is the incorporation of a fine particle size detackifier, which improves the coating process and final product quality. The film coating compositions can be applied directly to the substrate or to an existing subcoat, utilizing polymers such as polyvinyl alcohol or its copolymers. Additionally, it includes methods for applying these coatings and the coated substrates themselves, contributing to advancements in pharmaceutical formulation technology.

Career Highlights

Barry Friend is associated with Bpsi Holdings, Inc., where he continues to innovate within the field of film coatings. His work not only emphasizes the importance of effective pharmaceutical delivery systems but also showcases his commitment to improving patient outcomes through better product formulations.

Collaborations

Throughout his career, Barry has collaborated with talented professionals like Thomas P. Farrell and Jason Teckoe, enhancing the innovation process through teamwork and shared expertise. These collaborations have fostered an environment of creativity, leading to the development of effective and cutting-edge solutions in the pharmaceutical industry.

Conclusion

Barry Friend stands as a key figure in the realm of film coating technology, with his single patent reflecting an important advancement in oral dosage form coatings. His work at Bpsi Holdings, Inc. and his collaborations enhance the potential for future innovations in this critical field, underlining his significance as an inventor dedicated to improving pharmaceuticals and patient care.